Kezar Life Sciences Inc (KZR)

Apr 06, 2026

Baselake reports 5.3% stake in Kezar Life Sciences (NASDAQ: KZR) - Stock Titan

Apr 06, 2026

Apr 06, 2026

Does Kezar Life Sciences Inc meet Warren Buffetts criteria2026 Volatility Report & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn

Apr 06, 2026

Apr 06, 2026

Aurinia Pharmaceuticals acquiring Kezar Life Sciences - MSN

Apr 06, 2026

Apr 05, 2026

Kezar Life Sciences shares surge after Aurinia announces acquisition - MSN

Apr 05, 2026

Apr 04, 2026

Kezar Life Sciences Announces Lease Termination and Executive Separation Agreements in April 2026 - Minichart

Apr 04, 2026

Apr 04, 2026

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.96 Per Share Plus Contingent Value Rights in 2026 Merger Deal - Minichart

Apr 04, 2026

Apr 04, 2026

KZR PE Ratio & Valuation, Is KZR Overvalued - Intellectia AI

Apr 04, 2026

Apr 03, 2026

Kezar Life Sciences announces lease termination and executive departures following merger agreement - Investing.com Canada

Apr 03, 2026

Apr 03, 2026

Kezar Life Sciences Announces Major Executive Leadership Changes - TipRanks

Apr 03, 2026

Apr 03, 2026

Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline - TipRanks

Apr 03, 2026

Apr 03, 2026

Aurinia (NASDAQ: AUPH) to acquire Kezar with $6.955 per share cash and CVRs - Stock Titan

Apr 03, 2026

Apr 03, 2026

Kezar Life Sciences' Christopher J. Kirk, Marc L. Belsky and Mark Schiller to Depart under Separation Agreements - TradingView

Apr 03, 2026

Apr 03, 2026

Aurinia to acquire Kezar (NASDAQ: KZR) for $6.955 cash plus CVR - Stock Titan

Apr 03, 2026

Apr 02, 2026

KZR Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 02, 2026

Apr 01, 2026

Major Kezar (KZR) shareholder signs merger support pact and drops bid - Stock Titan

Apr 01, 2026

Mar 31, 2026

Aurinia Pharmaceuticals: $6.955 Per Share Acquisition Of Kezar Life Sciences To Expand Autoimmune Pipeline - pulse2.com

Mar 31, 2026

Mar 31, 2026

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right - Zenopa

Mar 31, 2026

Mar 31, 2026

Trend Recap: What is Kezar Life Sciences Incs market position2026 Chart Watch & Real-Time Stock Price Movement Reports - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

Aurinia to acquire Kezar Life Sciences - The Pharma Letter

Mar 31, 2026

Mar 31, 2026

Are KZR, NSA, EQH, CTRA Obtaining Fair Deals for their Shareholders? - Sahm

Mar 31, 2026

Mar 30, 2026

KZR Acquisition by Aurinia Pharmaceuticals Valued at $6.955 per Share - GuruFocus

Mar 30, 2026

Mar 30, 2026

Aurinia to Acquire Kezar Life Sciences (KZR) in Cash Deal - GuruFocus

Mar 30, 2026

Mar 30, 2026

Aurinia to Acquire Kezar Life Sciences (KZR) in Strategic Deal - GuruFocus

Mar 30, 2026

Mar 30, 2026

Jefferies maintains Kezar Life Sciences stock rating on acquisition By Investing.com - Investing.com India

Mar 30, 2026

Mar 30, 2026

Jefferies maintains Kezar Life Sciences stock rating on acquisition - Investing.com

Mar 30, 2026

Mar 30, 2026

After failed takeover bid, activist investor finds new way to buy out Bay Area company - The Business Journals

Mar 30, 2026

Mar 30, 2026

Aurinia Pharma U.S., Inc. agreed to acquire Kezar Life Sciences, Inc. for $51 million. - marketscreener.com

Mar 30, 2026

Mar 30, 2026

Shareholder Alert: The Ademi Firm investigates whether Kezar Lif - GuruFocus

Mar 30, 2026

Mar 30, 2026

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kezar Life Sciences, Inc. (NASDAQ: KZR) - PR Newswire

Mar 30, 2026

Mar 30, 2026

US Market Wrap: Does Kezar Life Sciences Inc meet Warren Buffetts criteria2026 Macro Moves & Consistent Return Investment Signals - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

Aurinia to acquire Kezar Life Sciences for $6.955 per share By Investing.com - Investing.com South Africa

Mar 30, 2026

Mar 30, 2026

Shareholder Alert: The Ademi Firm investigates whether Kezar Life Sciences, Inc. is obtaining a Fair Price for Public Shareholders - PR Newswire

Mar 30, 2026

Mar 30, 2026

Aurinia Pharmaceuticals Acquires Kezar Life Sciences - Contract Pharma

Mar 30, 2026

Mar 30, 2026

Aurinia to Buy Kezar Life Sciences in Cash-and-CVR Autoimmune Deal - TipRanks

Mar 30, 2026

Mar 30, 2026

Kezar Life Sciences stock jumps on Aurinia acquisition deal By Investing.com - Investing.com Australia

Mar 30, 2026

Mar 30, 2026

Kezar Life Sciences stock jumps on Aurinia acquisition deal - Investing.com

Mar 30, 2026

Mar 30, 2026

Kezar Life Sciences to Be Acquired by Aurinia in $6.955-Per-Share Cash Tender Offer Plus CVR - TradingView

Mar 30, 2026

Mar 30, 2026

Aurinia (NASDAQ: AUPH) to buy Kezar (NASDAQ: KZR) for $6.955 plus CVR - Stock Titan

Mar 30, 2026

Mar 30, 2026

KZR Stock Alert: Halper Sadeh LLC is Investigating Whether Kezar Life Sciences, Inc. is Obtaining a Fair Price for its Shareholders - The Joplin Globe

Mar 30, 2026

Mar 30, 2026

Aurinia to acquire Kezar Life Sciences for $6.955 per share - Investing.com

Mar 30, 2026

Mar 29, 2026

What is the next catalyst for Kezar Life Sciences Inc2026 Earnings Impact & Fast Moving Market Watchlists - baoquankhu1.vn

Mar 29, 2026

Mar 28, 2026

Kezar Life Sciences 2025 Annual Report: Strategic Alternatives, Clinical Pipeline, and Key Risks - Minichart

Mar 28, 2026

Mar 27, 2026

KZR: Net loss narrowed to $56M in 2025 as restructuring and strategic review efforts continued - TradingView

Mar 27, 2026

Mar 27, 2026

[10-K] Kezar Life Sciences, Inc. Files Annual Report - Stock Titan

Mar 27, 2026

Mar 27, 2026

Kezar Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 27, 2026

Mar 24, 2026

Kezar Life Sciences (KZR) to Release Earnings on Tuesday - Defense World

Mar 24, 2026